Sino Biological,Inc.

¥106.59As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301047Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (12.86%)
Div yield 1.88%
ROE 3.43%
Biotechnology
Beta (5Y) 0.84
PE TTM 72.40
TSR TTM 44.14%
Mkt cap ¥12.97B
ROIC 5.00%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥117
9.35%
(29.71%)
Sell 6|0|3|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.23
1.20
1.32
1.27
13.65%
11.80%
21.97%
9.75%
Revenue¥M
820.5
838.7
842.2
876.4
2.40%
(0.56%)
2.24%
4.39%
Peers (US$1.944B)
Cap (US$)
PE
1.944B
10.95x
Capital
TTM
5Y
10Y
Leveragex
0.845
0.303
0.257
EBIT/Intx
0.335
0.210
0.167
Own earn%
(96.74)
(18.32)
(14.40)
Sh yield%
23.68
18.34
18.73
Owners
Insiders/Inst%
0.33
49.11
Short interest%
1.22
SBC / revenue%
3.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
13–22
$1 testx
0.0
Incr. ROIC%
2